ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag biobusiness tuberculosis clinical trials regulation

Natural Killer Cell Therapies Catch Up to CAR T
Bianca Nogrady | Apr 1, 2020 | 8 min read
There’s a new cell-based cancer immunotherapy on the block.
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Bianca Nogrady | Oct 1, 2019 | 9 min read
The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.
Banking on iPSCs
Kerry Grens | Sep 1, 2014 | 5 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Banking on iPSCs
Kerry Grens | Jun 29, 2014 | 6 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
DNA Probes Yield Expanded Research And Clinical Uses
Ricki Lewis | Jan 9, 1994 | 10 min read
Author: Ricki Lewis Date:January 10, 1994, pp.17 The following vendors develop and/or market DNA probes for a variety of research and diagnostic purposes. For information about specific services, products, and prices, please contact these companies directly. Lofstrand Laboratories 7961 Cessna Ave. Gaithersburg, Md. 20879 (310) 330-0111 Fax: (301) 948-9214 Microbiological Associates Inc. Life Sciences Center 9900 Blackwell R
The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.

Run a Search

ADVERTISEMENT